HEMATOLOGIC NEOPLASMS
Clinical trials for HEMATOLOGIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC NEOPLASMS trials appear
Sign up with your email to follow new studies for HEMATOLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized stem cell transplant aims to beat inherited blood cancers
Disease control Not yet recruitingThis study tests whether adjusting chemotherapy doses for each patient can improve outcomes after a stem cell transplant for blood cancers caused by a RUNX1 gene mutation. Up to 98 people aged 4 to 70 with these cancers will receive a transplant from a half-matched donor. The goa…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a 30-Day habit shift help blood cancer patients regain control?
Disease control Not yet recruitingThis study tests a self-management program called Take5Care+ for adults recently diagnosed with slow-growing blood cancers. Participants choose a healthy habit—like better nutrition or more physical activity—and commit to it for 30 days. The goal is to see if this simple approach…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: NA • Sponsor: Jitka Vseteckova • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could peppermint oil mouthwash soothe chemo nausea?
Symptom relief Not yet recruitingThis study tests whether a peppermint oil mouthwash can help reduce nausea, vomiting, and loss of appetite caused by chemotherapy in people with blood cancers. 72 patients will be split into two groups: one gets standard oral care, the other rinses with peppermint oil three times…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: NA • Sponsor: Şule Güzle • Aim: Symptom relief
Last updated Jun 26, 2026 17:48 UTC
-
Blood cancer patients may need higher antibiotic doses to beat superbugs
Knowledge-focused Not yet recruitingThis study looks at whether the standard dose of the antibiotic ceftazidime-avibactam reaches high enough levels in the blood of people with blood cancers or those who have had a stem cell transplant. These patients are at high risk for severe infections from drug-resistant bacte…
Matched conditions: HEMATOLOGIC NEOPLASMS
Sponsor: Sizhou Feng • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New study aims to predict bleeding and clotting risks in cancer patients
Knowledge-focused Not yet recruitingThis observational study will measure how well the body breaks down blood clots in 150 cancer patients (with blood cancers or solid tumors) who also have clotting issues. Researchers will take extra blood samples during routine care to look for markers that might predict bleeding…
Matched conditions: HEMATOLOGIC NEOPLASMS
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC